Psilocybin, Ketamine, and MDMA in Cancer Care: Next Steps in Psychedelic Research
June 24th 2025Manish Agrawal, MD, explores the evolving role of pharmacists in psychedelic-assisted therapy, highlighting ongoing efforts to develop standardized protocols and the emerging involvement of pharmacy teams in patient education and safety.
Read More
Psychedelic Group Therapy Expands From Cancer Care to Treat PTSD in Active Duty Military
June 23rd 2025Manish Agrawal, MD, discusses the expanding influence of his group-based psychedelic therapy model in oncology and beyond, highlighting its adaptation in military post-traumatic stress disorder (PTSD) research, the sustained benefits of long-term patient integration, and growing institutional interest in psychedelic-assisted therapy.
Read More
Psychedelic Science 2025: Clinical Perspectives on Psychedelics in Palliative Oncology
June 16th 2025Manish Agrawal, MD, discusses emerging research on psychedelic-assisted therapy for patients with cancer, including innovative dyadic treatment models, challenges in capturing meaningful outcomes, and growing interest in integrating psychedelics into oncology and palliative care.
Read More